Evidence map›Paper›PMID 39779897›Full record

ReviewNature protocols2025

Lymphatic collection and cell isolation from mouse models for multiomic profiling.

Marie Sabatier, Ani Solanki, Sangeetha Thangaswamy, Pin-Ji Lei, Hengbo Zhou, Meghan O'Melia, Lutz Menzel, Samir Mitri, Jessalyn M Ubellacker

Erratum issuedAbstract readReview
In one paragraph

Review in Nature protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Marie SabatierDepartment of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA.ORCID 0000-0001-7673-4842
Ani SolankiAnimal Resources Center, University of Chicago, Chicago, IL, USA.
Sangeetha ThangaswamyLegend Biotech, Somerset, NJ, USA.
Pin-Ji LeiEdwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Hengbo ZhouEdwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Meghan O'MeliaEdwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Lutz MenzelEdwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Samir MitriBreast Surgical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Jessalyn M UbellackerDepartment of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA. jubellacker@hsph.harvard.edu.ORCID 0000-0002-7855-9125

Funding

Preventing Melanoma Metastasis by Targeting Lipid Vulnerabilities in LymphR01CA282202 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Jessalyn Ubellacker · 2024 to 2026
$1.3M
Breast Cancer Alliance (BCA) N/ADana-Farber/Harvard Cancer Center (DF/HCC) N/AMelanoma Research Foundation (MRF) N/ANCI NIH HHS R01 CA282202U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) 1R01CA282202
6 · The paper itself

Abstract

Premetastatic cancer cells often spread from the primary lesion through the lymphatic vasculature and, clinically, the presence or absence of lymph node metastases impacts treatment decisions. However, little is known about cancer progression via the lymphatic system or of the effect that the lymphatic environment has on cancer progression. This is due, in part, to the technical challenge of studying lymphatic vessels and collecting lymph fluid. Here we provide a step-by-step procedure to collect both lymph and tumor-draining lymph in mouse models of cancer metastasis. This protocol has been adapted from established methods of lymph collection and was developed specifically for the collection of lymph from tumors. The approach involves the use of mice bearing melanoma or breast cancer orthotopic tumors. After euthanasia, the cisterna chyli and the tumor are exposed and viewed using a stereo microscope. Then, a glass cannula connected to a 1 mL syringe is inserted directly into the cisterna chyli or the tumor-draining lymphatics for collection of pure lymph. These lymph samples can be used to analyze the lymph-derived cancer cells using highly sensitive multiomics approaches to investigate the impact of the lymph environment during cancer metastasis. The procedure requires 2 h per mouse to complete and is suitable for users with minimal expertise in small animal handling and use of microsurgical tools under a stereo microscope.

Indexed as

Cell SeparationLymphLymphatic VesselsAnimalsDisease Models, AnimalFemaleLymphatic MetastasisMice

Identifiers

PMID39779897
PMCPMC13032124

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.